Logo image of TSAT

TELESAT CORP (TSAT) Stock Fundamental Analysis

USA - NASDAQ:TSAT - CA8795123097 - Common Stock

24.31 USD
-1.03 (-4.06%)
Last: 9/18/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TSAT. TSAT was compared to 35 industry peers in the Diversified Telecommunication Services industry. Both the profitability and the financial health of TSAT get a neutral evaluation. Nothing too spectacular is happening here. TSAT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year TSAT has reported negative net income.
TSAT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: TSAT reported negative net income in multiple years.
In the past 5 years TSAT always reported a positive cash flow from operatings.
TSAT Yearly Net Income VS EBIT VS OCF VS FCFTSAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

TSAT has a Return On Assets of -1.52%. This is comparable to the rest of the industry: TSAT outperforms 42.86% of its industry peers.
TSAT has a Return On Equity of -15.22%. This is in the lower half of the industry: TSAT underperforms 71.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.87%, TSAT is in line with its industry, outperforming 45.71% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TSAT is below the industry average of 6.32%.
Industry RankSector Rank
ROA -1.52%
ROE -15.22%
ROIC 1.87%
ROA(3y)0.29%
ROA(5y)1.38%
ROE(3y)2.17%
ROE(5y)9.65%
ROIC(3y)3.76%
ROIC(5y)4.41%
TSAT Yearly ROA, ROE, ROICTSAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

The Operating Margin of TSAT (29.03%) is better than 94.29% of its industry peers.
In the last couple of years the Operating Margin of TSAT has declined.
TSAT has a better Gross Margin (94.43%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of TSAT has remained more or less at the same level.
Industry RankSector Rank
OM 29.03%
PM (TTM) N/A
GM 94.43%
OM growth 3Y-0.65%
OM growth 5Y-5.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y-0.54%
TSAT Yearly Profit, Operating, Gross MarginsTSAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TSAT is destroying value.
The number of shares outstanding for TSAT has been increased compared to 1 year ago.
TSAT has less shares outstanding than it did 5 years ago.
TSAT has a better debt/assets ratio than last year.
TSAT Yearly Shares OutstandingTSAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TSAT Yearly Total Debt VS Total AssetsTSAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

TSAT has an Altman-Z score of 0.56. This is a bad value and indicates that TSAT is not financially healthy and even has some risk of bankruptcy.
TSAT's Altman-Z score of 0.56 is on the low side compared to the rest of the industry. TSAT is outperformed by 65.71% of its industry peers.
A Debt/Equity ratio of 4.71 is on the high side and indicates that TSAT has dependencies on debt financing.
TSAT's Debt to Equity ratio of 4.71 is on the low side compared to the rest of the industry. TSAT is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.71
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC0.32
WACC5.77%
TSAT Yearly LT Debt VS Equity VS FCFTSAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

2.3 Liquidity

A Current Ratio of 5.08 indicates that TSAT has no problem at all paying its short term obligations.
TSAT's Current ratio of 5.08 is amongst the best of the industry. TSAT outperforms 97.14% of its industry peers.
TSAT has a Quick Ratio of 5.08. This indicates that TSAT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.08, TSAT belongs to the best of the industry, outperforming 97.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.08
Quick Ratio 5.08
TSAT Yearly Current Assets VS Current LiabilitesTSAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

The earnings per share for TSAT have decreased strongly by -34.84% in the last year.
Looking at the last year, TSAT shows a very negative growth in Revenue. The Revenue has decreased by -24.21% in the last year.
Measured over the past years, TSAT shows a decrease in Revenue. The Revenue has been decreasing by -8.92% on average per year.
EPS 1Y (TTM)-34.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.31%
Revenue 1Y (TTM)-24.21%
Revenue growth 3Y-9.02%
Revenue growth 5Y-8.92%
Sales Q2Q%-30.39%

3.2 Future

Based on estimates for the next years, TSAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -25.06% on average per year.
Based on estimates for the next years, TSAT will show a quite strong growth in Revenue. The Revenue will grow by 15.49% on average per year.
EPS Next Y-17.42%
EPS Next 2Y-54.85%
EPS Next 3Y-25.06%
EPS Next 5YN/A
Revenue Next Year-26.26%
Revenue Next 2Y-20.55%
Revenue Next 3Y-7.09%
Revenue Next 5Y15.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TSAT Yearly Revenue VS EstimatesTSAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
TSAT Yearly EPS VS EstimatesTSAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TSAT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSAT Price Earnings VS Forward Price EarningsTSAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

TSAT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.41
TSAT Per share dataTSAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

A cheap valuation may be justified as TSAT's earnings are expected to decrease with -25.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.85%
EPS Next 3Y-25.06%

0

5. Dividend

5.1 Amount

No dividends for TSAT!.
Industry RankSector Rank
Dividend Yield N/A

TELESAT CORP

NASDAQ:TSAT (9/18/2025, 8:00:01 PM)

24.31

-1.03 (-4.06%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners56.89%
Inst Owner Change-0.16%
Ins Owners5.98%
Ins Owner Change0%
Market Cap1.24B
Analysts80
Price Target32.13 (32.17%)
Short Float %5.57%
Short Ratio7.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)162.74%
Min EPS beat(2)139.87%
Max EPS beat(2)185.61%
EPS beat(4)3
Avg EPS beat(4)148.14%
Min EPS beat(4)-110.16%
Max EPS beat(4)377.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.7%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)4.03%
Revenue beat(4)2
Avg Revenue beat(4)0.42%
Min Revenue beat(4)-5.43%
Max Revenue beat(4)4.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-37.34%
EPS NQ rev (3m)-37.34%
EPS NY rev (1m)25.44%
EPS NY rev (3m)11.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.5
P/FCF N/A
P/OCF 16.41
P/B 2.53
P/tB N/A
EV/EBITDA 15.41
EPS(TTM)-3.44
EYN/A
EPS(NY)-9.5
Fwd EYN/A
FCF(TTM)-17.09
FCFYN/A
OCF(TTM)1.48
OCFY6.09%
SpS6.95
BVpS9.6
TBVpS-32.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.52%
ROE -15.22%
ROCE 2.16%
ROIC 1.87%
ROICexc 2.04%
ROICexgc 4.02%
OM 29.03%
PM (TTM) N/A
GM 94.43%
FCFM N/A
ROA(3y)0.29%
ROA(5y)1.38%
ROE(3y)2.17%
ROE(5y)9.65%
ROIC(3y)3.76%
ROIC(5y)4.41%
ROICexc(3y)4.87%
ROICexc(5y)5.57%
ROICexgc(3y)14.76%
ROICexgc(5y)17.44%
ROCE(3y)4.34%
ROCE(5y)5.08%
ROICexcg growth 3Y-28.13%
ROICexcg growth 5Y-25.47%
ROICexc growth 3Y-17.12%
ROICexc growth 5Y-18.41%
OM growth 3Y-0.65%
OM growth 5Y-5.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y-0.54%
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 4.71
Debt/FCF N/A
Debt/EBITDA 11.33
Cap/Depr 938.76%
Cap/Sales 267.27%
Interest Coverage 0.8
Cash Conversion 37.08%
Profit Quality N/A
Current Ratio 5.08
Quick Ratio 5.08
Altman-Z 0.56
F-Score3
WACC5.77%
ROIC/WACC0.32
Cap/Depr(3y)301.38%
Cap/Depr(5y)217.49%
Cap/Sales(3y)74.26%
Cap/Sales(5y)55.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.31%
EPS Next Y-17.42%
EPS Next 2Y-54.85%
EPS Next 3Y-25.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.21%
Revenue growth 3Y-9.02%
Revenue growth 5Y-8.92%
Sales Q2Q%-30.39%
Revenue Next Year-26.26%
Revenue Next 2Y-20.55%
Revenue Next 3Y-7.09%
Revenue Next 5Y15.49%
EBIT growth 1Y-47.95%
EBIT growth 3Y-9.61%
EBIT growth 5Y-14.06%
EBIT Next Year-11.36%
EBIT Next 3Y-3.2%
EBIT Next 5Y26.1%
FCF growth 1Y-834.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.17%
OCF growth 3Y-40.49%
OCF growth 5Y-30.15%